Use of Cardioprotective Antidiabetic Medications in Adults With and Without Cardiovascular Disease, 2015 to March 2020.

Published in: The Annals of pharmacotherapy (2023)

Despite preferential use in individuals with diabetes and CVD, the prevalence of cardioprotective antidiabetic medication use remains relatively low. Disparities in use appear to exist based on income level and health care utilization.

Keyphrases

cardiovascular disease
healthcare
type diabetes
risk factors
physical activity
mental health
affordable care act
glycemic control
cardiovascular events
cardiovascular risk factors
metabolic syndrome
weight loss
skeletal muscle